Abstract:BackgroundLittle is known about the characteristics of patients with psoriatic arthritis (PsA) during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to evaluate the impact of COVID-19 on PsA progression and comprehend the role of COVID-19 vaccination in the infection course.MethodsA total of 163 adult patients with PsA from 15 provinces in China were enrolled in this multiregional observational study from January 14, 2023, to March 22, 2023. Data on patient demographics, COVID-19 status, and disease characteristics were collected through a structured questionnaire survey.ResultsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could worsen PsA, with 29.0% of patients experiencing deteriorating symptoms. Psoriasis was the symptom most exacerbated (61.1%), followed by peripheral arthritis (52.8%) and dactylitis (25.0%). Compared with the patients whose arthritic condition was stable before contracting COVID-19, those with active PsA experienced more severe COVID-19 symptoms, reporting higher self-assessed symptom severity scores and a greater prevalence of dyspnea (42.9% vs. 7.3%). Moreover, although full vaccination (>= 2 doses) could not prevent COVID-19, it could alleviate the infection symptoms, including diarrhea, fatigue, appetite changes, and spondyloarthritis. Additionally, fully vaccinated individuals had a higher probability of avoiding deterioration of their PsA condition after infection.ConclusionActive PsA and lack of COVID-19 vaccination are risk factors for worsening COVID-19 symptoms and PsA condition after infection. The evidence from this real-world study suggests that COVID-19 may exacerbate PsA. Psoriatic arthritis (PsA) and COVID-19 interact reciprocally. Patients with PsA may experience an exacerbation of the condition after SARS-CoV-2 infections. Furthermore, individuals with active PsA were more likely to manifest pronounced dyspnea symptoms in the presence of COVID-19. Administration of a full dose regimen (>= 2 doses) of the COVID-19 vaccine has been shown to effectively reduce symptoms such as diarrhea, fatigue, appetite changes, and axial joint pain in patients with PsA. COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. image This report presents the empirical manifestation of comprehensive and systematic observational research into the reciprocal effects of coronavirus disease 2019 (COVID-19) and psoriatic arthritis (PsA) in a large multiregional cohort of patients with PsA in China. The research highlights the characteristics of COVID-19 symptoms, the effect of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with PsA, and the factors that exacerbate the PsA condition after infection. The study findings can help clinicians make appropriate management decisions for patients with PsA during future pandemics involving respiratory coronaviruses.

Post-COVID-19 arthritis: a case report and literature review

Knee osteonecrosis after SARS-CoV-2 infection: a systematic case-based review

Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature

Acute Respiratory Distress Syndrome and COVID-19: A Literature Review

Mechanisms of musculoskeletal consequences of COVID-19

Inflammatory Arthritis Post Covid-19 Infection.

Polymyalgia Rheumatica Post-SARS-CoV-2 Infection

Anti-OJ antibody-positive anti-synthetase syndrome following SARS-CoV-2 infection: a case report and literature review

COVID-19-Induced Rheumatoid Arthritis: Case Series and Systematic Review of the Literature

Speculation on the pathophysiology of musculoskeletal injury with COVID-19 infection

The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches

Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies

SARS-COV-2 INFECTION AND INVOLVEMENT OF PERIPHERAL NERVOUS SYSTEM: A CASE SERIES OF CARPAL TUNNEL SYNDROME AGGRAVATION OR NEW ONSET WITH COVID-19 DISEASE AND A REVIEW OF LITERATURE

Examination of SARS-CoV-2 RNA in joint synovial fluid of patients with COVID-19 and acute knee arthritis

Progression from palindromic rheumatism to rheumatoid arthritis after COVID-19 vaccination

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

A Related PRISMA Systematic Literature Review

Coronavirus Disease 2019 and Psoriatic Arthritis: Features and Connections

COVID-19 with rheumatic diseases: a report of 5 cases

Diagnostic considerations in the clinical management of sudden swelling of the knee: a case report and review of the literature

Circulating levels of inflammatory cytokines and angiogenesis-related growth factors in patients with osteoarthritis after COVID-19